Cures Start Here. At Fred Hutchinson Cancer Research Center, home to three Nobel laureates, interdisciplinary teams of world-renowned scientists seek new and innovative ways to prevent, diagnose and treat cancer, HIV/AIDS and other life-threatening diseases. Fred Hutch\u2019s pioneering work in bone marrow transplantation led to the development of immunotherapy, which harnesses the power of the immune system to treat cancer. An independent, nonprofit research institute based in Seattle, Fred Hutch houses the nation\u2019s first cancer prevention research program, as well as the clinical coordinating center of the Women\u2019s Health Initiative and the international headquarters of the HIV Vaccine Trials Network. Careers Start Here.
Seattle Translational Tumor Research (STTR) creates environments which enable researchers and clinicians to accelerate scientific discovery and translate it into cures for patients; and has three main objectives:
Build seamless infrastructure to optimize and speed translational and precision medicine research
Strengthen tumor-specific translational research programs across liquid and solid tumors
Strengthen partnerships between Seattle-area translational research institutions
STTR is currently implementing a survey of Fred Hutch-based faculty and staff. The survey is intended as a landscape assessment and needs gathering activity to inform STTR and Fred Hutch leadership about the current state of informatics needs and support across Fred Hutch.
Our goal is to use the results to inform the development of the translational research pipeline by better understanding bottlenecks and barriers to large-scale translational research. By understanding which data types are most commonly used in research projects, we can help inform the development of new tools in Oncoscape ( http://oncoscape.sttrcancer.org/#/ ) to enable more novel approaches to data visualization and analysis (in partnership with interested informatics/computational faculty). We can also use the data to work with groups across Fred Hutch (HDC and the Translational Genomics Data Coordinating Center) to help researchers access the tools and technologies needed to navigate this space, and to help develop and increase access to best practices and data standards in this space. In addition, this survey will allow STTR to more effectively connect investigators (both clinical and wet lab) to resources for informatics support across the Fred Hutch investigator network.
To date, we have surveyed over 60 clinicians, researchers and staff across Fred Hutch and have conducted preliminary analyses of findings using the quantitative data generated from our survey. We hope to take our analysis deeper and draw further connections amongst investigators through further analysis of this data set and through analysis of the qualitative data collected through the survey. Working alongside various groups at Fred Hutch, such as Center IT, the Hutch Data Commonwealth, and faculty from the Computational Biology division we plan to use this information to identify or develop effective bioinformatics solutions that advance researcher\u2019s abilities to conduct large-scale translational research.
At Fred Hutchinson Cancer Research Center, teams of world-renowned scientists and humanitarians work together to prevent, diagnose and treat cancer, HIV/AIDS and other diseases. Researchers are discovering new ways to detect cancers earlier, improve treatments, and learn how to prevent cancers from growing. Although Fred Hutchinson opened its doors in 1975, its history began about 20 years before that. In 1962 Fred Hutchinson envisioned a center devoted to studying cancer, a disease that took his brother’s life. Today Fred Hutchinson is contributing to the next waves of breakthrough treatments and prevention strategies. Fred Hutchinson collaborates with the Seattle Cancer Alliance, the National Cancer Institute, and the University of Washington.